High Impact Pharmaceuticals: A Review of Relatively Low Volume Pharmacy Cost-drivers
Pharmacy costs continue to represent a substantial portion of overall spending in healthcare. Claim closures and reductions in compounds and opioids have helped to lower some of these costs, however, so-called “price opportunists” continue to emerge along with specialty treatments and new, innovative therapeutics.
Dates: Wednesday, August 12 and a repeat session on Wednesday, August 26
Time: 2-3 PM Eastern Time
Presenter: Nikki Wilson, Pharm. D., MBA, Director of Pharmacy Product Development, Coventry
CEUs Pending: CA, DE, FL, GA, IN, KY, LA, MN, NC, NH, NV, OK, TX and CCM and RN nationwide
To see more from Coventry, please click here.